LYEL
Lyell Immunopharma Inc
9.70$
-1.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | 96.4% | 136.5% | 19.4% | 15,576.9% | – | 32,052.8% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -31,952.8% | |
| 9,679.6% | 2,349.7% | 1,302.3% | 188.0% | 140,726.9% | 281,316.4% | 440,763.9% | |
| 5,959.1% | 604.4% | 836.2% | 138.5% | 51,525.4% | 85,313.1% | 125,375.0% | |
| 15,638.7% | 2,832.6% | 2,116.7% | 320.9% | 190,106.2% | 588,223.0% | 534,086.1% | |
| -15,538.7% | -2,732.6% | -2,016.7% | -220.9% | -190,006.2% | -588,123.0% | -566,038.9% | |
| 0.0% | 76.6% | 10.9% | – | – | – | – | |
| -19,692.1% | -2,636.3% | -2,349.5% | -216.2% | -180,486.2% | -562,285.2% | -762,355.6% | |
| -1,236.1% | -76.6% | 331.3% | -210.6% | -8,100.0% | – | – | |
| -19,692.1% | -2,636.3% | -2,349.5% | -216.2% | -180,486.2% | -562,285.2% | -762,355.6% | |
| -15,347.5% | -2,777.6% | -2,221.5% | -195.0% | -164,909.2% | -328,923.0% | -730,302.8% |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.